No Detail Found!

Nitroglycerin plus clopidogrel for acute myocardial infarction and the effect on cardiac function indices

Author(s)
Cui Xie Department of Cardiovascular Medicine, Hubei University of Medicine,Hubei Province,China
Miao He Department of Peds, Renmin Hospital, Hubei University of Medicine,Hubei Province,China
Yang Xiang Department of Cardiovascular Medicine, Hubei University of Medicine,Hubei Province,China
Abstract
To evaluate the efficacy of nitroglycerin plus clopidogrel for acute myocardial infarction and the effect on the cardiac function indices. From April 2019 to April 2020, 90 patients with acute myocardial infarction enrolled in our hospital were recruited and assigned to receive either oral clopidogrel (control group) or nitroglycerin plus clopidogrel (experimental group), with 45 cases in each group. Outcome measures included clinical efficacy, inflammatory factors, cardiac function indices, myocardial enzymatic indexes, Selvester QRS score, myocardial infarction area and quality of life. Nitroglycerin plus clopidogrel resulted in significantly higher treatment efficiency versus clopidogrel alone (P<0.05). Patients with nitroglycerin plus clopidogrel showed significantly reduced levels of inflammatory factors, a lower ST reduction and a lower end-systolic volume index (ESVI) versus those with single clopidogrel (P<0.05). Nitroglycerin plus clopidogrel was associated with a shorter prothrombin time, higher end-diastolic volume index (EDVI) and SF-36 scores and lower myocardial enzymatic indexes and QRS scores versus clopidogrel (P<0.05). Patients with combined therapy had a smaller myocardial infarction area than those with monotherapy (P<0.05). Nitroglycerin plus clopidogrel ameliorates the cardiac function indices of patients with acute myocardial infarction, mitigates the inflammatory responses, and improves the patient's quality of life. Further research is required prior to clinical promotion.
Publication Details
Page(s) 973-979
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S3, Year: 2023

Request the full text from PASTIC

Keywords
Nitroglycerin, Acute Myocardial Infarction, clopidogrel, cardiac function index
References
Ahn JH,Ahn Y,Jeong MH,Kim JH,Hong YJ,Sim DS,Kim MC,Hwang JY,Yoon JH,Seong IW,Hur SH,Oh SK .2020 .Ticagrelor versus clopidogrel in acute myocardial infarction patients who have multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health. , 75(5) : 478-484.
Altıntaş B,Altındağ R,Bilge Ö,Baysal E,Öztürk Ö,Yaylak B,Ede H,Karahan MZ,Burak C,Tanboğa İH C .2019 .The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction. Int. J. Cardiol., 287 : 19-26.
Davis EM,Knezevich JT,Teply RM .2021 .Comparison of P2Y12 receptor inhibitors in patients who have ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries. Eur. Heart J. Cardiovasc. Pharmacother., 7(2) : 94-103.
Doll JA,Li S,Chiswell K,Roe MT,Kosiborod M,Scirica BM,Wang TY .2018 .Clopidogrel reloading for patients who have acute myocardial infarction already on clopidogrel therapy. Eur. Heart J., 39(3) : 193-200.
Edfors R,Sahlén A,Szummer K,Renlund H,Evans M,Carrero JJ,Spaak J,James SK,Lagerqvist B,Varenhorst C,Jernberg T C .2018 .Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function. Heart, 104(19) : 1575-1582.
Gasecka A,Nieuwland R,Budnik M,Dignat-George F,Eyileten C,Harrison P,Lacroix R,Leroyer A,Opolski G,Pluta K,van der Pol E,Postuła M,Siljander P,Siller-Matula JM,Filipiak KJ JM,Thromb JM .2020 .Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel. , 18(3) : 609-623.
Gong IY,Yan AT,Ko DT,Earle CC,Cheung WY,Peacock S,Chan KKW .2018 .Temporal changes in therapys and outcomes after acute myocardial infarction among cancer survivors and patients who haveout cancer, 1995 to 2013. , 124(6) : 1269-1278.
Hariri E,Lessard D,Gore J,Rade J,Goldberg R .2020 .Are we optimizing the use of dual antiplatelet therapy in patients hospitalized with acute myocardial infarction? Cardiovasc. , 21(2) : 182-188.
Ibrahim H,Kaltenbach LA,Hess CN,Recchia T,Effron MB,Stone GW,Wang TY .2019 .Glycoprotein IIb/IIIa inhibitor use in patients who have acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS research. Catheter. Cardiovasc. Interv, 93(4) : E204-E210.
Kang J,Han JK,Ahn Y,Chae SC,Kim YJ,Chae IH .2018 .ThirdGeneration P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre research. Thromb. Haemost, 118(3) : 591-600.
Kim C,Shin DH,Hong SJ,Ahn CM,Kim JS,Kim BK,Jang Y .2019 .One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients who have acute myocardial infarction: From Korean Health Insurance Review and Assessment Data. , 73(3) : 191-197.
Komócsi A,Aradi D,Szűk T,Nagy GG,Noori E,Ruzsa Z,Kiss RG,Andrássy P,Nagy L,Nagy FT,Lupkovics G,Kőszegi Z,Dézsi CA,Papp E,Molnár Z,Kupó P,Ofner P,Merkely B,Jánosi A .2018 .Comparison of platelet function guided versus unguided therapy with p2y12 inhibitors in patients who have acute myocardial infarction (from the Hungarian Myocardial Infarction Registry). Am. J. Cardiol., 121(10) : 1129-1137.
Lee CH,Cheng CL,Kao Yang YH,Chao TH,Chen JY,Li YH .2018 .Cardiovascular and bleeding risks in acute myocardial infarction newly treated with ticagrelor vs. clopidogrel in Taiwan. , 82(3) : 747-756.
Lee CH,Tsai TH,Lin CJ,Hsueh SK,Chung WJ,Cheng CI .2019 .Efficacy and safety of ticagrelor compared with clopidogrel in patients who have endstage renal disease with acute myocardial infarction. Am. J. Cardiovasc Drugs, 19(3) : 325-334.
Lee HL,Kim JT,Lee JS,Park MS,Choi KH,Cho KH,Kim BJ,Park JM,Kang K,Lee SJ,Kim JG,Cha JK,Kim DH,Park TH,Park SS,Lee KB,Lee J,Hong KS,Cho YJ,Park HK,Lee BC,Yu KH,Sun Oh M,Kim DE,Ryu WS,Choi JC,Kwon JH,Kim WJ,Shin DI,Sohn SI,Hong JH,Lee J,Bae HJ .2020 .Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in mild-to-moderate acute ischemic stroke according to the risk of recurrent stroke: An analysis of 15000 patients from a nationwide, multicenter registry. Circ. Cardiovasc. Qual Outcomes, 13(11) : e006474.
Mohammad HMF,Makary S,Atef H,El-Sherbiny M,Atteia HH,Ibrahim GA,Zaitone SA .2020 .Clopidogrel or prasugrel reduces mortality and lessens cardiovascular damage from acute myocardial infarction in hypercholesterolemic male rats. Life Sci, 247 : 117429.
Park KH,Jeong MH,Kim HK,Ahn TH,Seung KB,Oh DJ,Investigators K-NR .2018 .Comparison of prasugrel versus clopidogrel in Korean patients who have acute myocardial infarction undergoing successful revascularization. J. Cardiol., 71(1) : 36-43.
Pavlovic M,Apostolovic S,Stokanovic D,Lilic J,Konstantinovic SS,Zvezdanovic JB,Nikolic VN .2019 .The association between clopidogrel and 2- oxo-clopidogrel plasma levels and the long-term clinical outcome after acute myocardial infarction. Int. J. Clin. Pharmacol, 57(2) : 82-93.
Sabbah M,Nepper-Christensen L,Kober L,Hofsten DE,Ahtarovski KA,Goransson C,Engstrom T C .2020 .Infarct size following loading with ticagrelor/ prasugrel versus clopidogrel in ST-segment elevation myocardial infarction. Int. J. Cardiol., 314 : 7-12.
Ulvenstam A,Henriksson R,Soderstrom L,Mooe T .2018 .Ischemic stroke rates decrease with increased ticagrelor use after acute myocardial infarction in patients treated with percutaneous coronary intervention. Eur. J. Prev. Cardiol., 25(11) : 1219-1230.
Wang C,Zheng W,Shaqdan A,Wang C,Qin X,Zhao X,Wang X,Yuan L,Nie S,Liu R .2020 .Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention. Platelets, 31(3) : 337-343.
Wang MT,Liang HL,Hung CC,Tang PL,Lin KC,Chiang CH,Huang WC .2019 .Combination therapy with dipyridamole and clopidogrel for secondary stroke prevention in aspirin-intolerant patients after myocardial infarction: results of a nationwide case-control research. CNS Drugs, 33(2) : 175-185.
Yasuda S,Honda S,Takegami M,Nishihira K,Kojima S,Asaumi Y,Suzuki M,Kosuge M,Takahashi J,Sakata Y,Takayama M,Sumiyoshi T,Ogawa H,Kimura K,JAMIR Investigators K .2019 .Contemporary antiplatelet therapy and clinical outcomes of Japanese patients who have acute myocardial infarction-results from the prospective japan acute myocardial infarction registry (JAMIR). Circ. , 83(8) : 1633-1643.
Zhang Y,Shao T,Yao L,Yue H,Zhang Z H .2018 .Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction. Exp. Ther. Med, 16(4) : 3383-3388.
Zhang YR,Xue ZK,Chen KY,Xu LX,Wang WD,Tao HY,Liu T,Che JJ,Wang XW,Rha SW,Wang JR,Wang P .2021 .Loading doses of ticagrelor versus clopidogrel in preventing periprocedural myocardial infarction in Asian patients who have acute coronary syndrome. Perfusion, 36(2) : 122-129.
0

Citations

0

Downloads

72

Views